Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies.
J Natl Cancer Inst. 2022 Mar 8;114(3):436-445. doi: 10.1093/jnci/djab194.
J Natl Cancer Inst. 2022.
PMID: 34581788
Free PMC article.